Confluence Investment Management LLC Increases Position in Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Confluence Investment Management LLC raised its position in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP) by 0.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 73,839 shares of the company’s stock after buying an additional 633 shares during the period. Confluence Investment Management LLC’s holdings in Crescent Capital BDC were worth $1,419,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also modified their holdings of the company. HighTower Advisors LLC boosted its holdings in Crescent Capital BDC by 0.5% during the 3rd quarter. HighTower Advisors LLC now owns 141,838 shares of the company’s stock valued at $2,624,000 after acquiring an additional 768 shares during the period. Point72 Asset Management L.P. acquired a new stake in shares of Crescent Capital BDC during the second quarter worth about $90,000. XTX Topco Ltd purchased a new position in shares of Crescent Capital BDC in the second quarter valued at approximately $195,000. Pettinga Financial Advisors LLC grew its holdings in shares of Crescent Capital BDC by 95.8% in the third quarter. Pettinga Financial Advisors LLC now owns 29,017 shares of the company’s stock valued at $537,000 after purchasing an additional 14,200 shares in the last quarter. Finally, Van ECK Associates Corp increased its stake in Crescent Capital BDC by 136.1% during the 2nd quarter. Van ECK Associates Corp now owns 26,521 shares of the company’s stock worth $498,000 after buying an additional 15,288 shares during the period. 49.46% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have commented on the stock. Keefe, Bruyette & Woods raised their price target on shares of Crescent Capital BDC from $19.00 to $20.00 and gave the company an “outperform” rating in a research report on Monday, November 25th. LADENBURG THALM/SH SH started coverage on Crescent Capital BDC in a report on Monday, September 30th. They issued a “buy” rating and a $20.00 target price for the company. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $19.17.

Crescent Capital BDC Stock Performance

NASDAQ:CCAP opened at $19.21 on Friday. Crescent Capital BDC, Inc. has a 12 month low of $15.91 and a 12 month high of $20.03. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.26 and a quick ratio of 1.26. The firm has a market capitalization of $711.96 million, a PE ratio of 7.53 and a beta of 0.82. The business’s fifty day moving average price is $19.10 and its 200 day moving average price is $18.75.

Crescent Capital BDC Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.42 per share. This represents a $1.68 annualized dividend and a dividend yield of 8.75%. The ex-dividend date is Tuesday, December 31st. This is a positive change from Crescent Capital BDC’s previous quarterly dividend of $0.07. Crescent Capital BDC’s dividend payout ratio (DPR) is 65.88%.

Crescent Capital BDC Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.